Share on LinkedInShare on LinkedIn

ARTICLE · 25 OCTOBER 2012

Supreme Court Of Canada Decides Transfer Pricing Case - Canada v. GlaxoSmithKline Inc.

In its recently-released judgement in Canada v. GlaxoSmithKline Inc.[1] the Supreme Court of Canada has considered transfer pricing tax issues for the first time.

CanadaTax


In its recently-released judgement in Canada v. GlaxoSmithKline Inc.1 the Supreme Court of Canada has considered transfer pricing tax issues for the first time.  This decision is important to multi-national enterprises ("MNEs") because the Supreme Court makes it clear that Canadian courts have broad scope to determine whether prices used for the transfer of property or services between a Canadian resident taxpayer and non-arm's length non-residents are reasonable.  The Supreme Court agreed with the Federal Court of Appeal in overturning the original decision of the Tax Court of Canada (the "Tax Court") to essentially confirm the income tax reassessment of GlaxoSmithKline Inc. ("Glaxo Canada") issued by the Minister of National Revenue (the "Minister"). The Tax Court held that the reasonableness of transfer pricing should be determined on a strict transaction-by-transaction basis and other agreements or transactions entered into by the parties should be

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from